What ever you do, do it with passion or et least with style! We in Medical Devices and eHealth stand for life changing combinations of medical devices together with our drugs. I´m proudly presenting the eHealth & Medical Software Solution team. Our joint vision is that every patient should get access to break trough eHealth solutions. Come and visit us - go/MDeH - or connect with me via Linkedin. Always keen to chat about "AI applied in med tech", "data mech in clinical practice", "if compliance and agility can coexist" & "how to get form a research hypothesis or concept to a data product"

I am Lead Business Technology Manager with Bayer, from Hyderabad, India. I have total 14 years of experience in various capacities on both business and technology side.

I've met Miriam during a DS&AI meeting in May 2023 in Madrid. She works as a Data Steward within Data Strategy and Governance in the group Proprietary Information Management. She is a (computational) chemist by training and has particular experience with our chemical labjournal data.

Thank you for connecting! This token shall commemorate our friendship! :)

Given the considerable amount of data that is collected throughout clinical trials, it can be asked if this data can be used to improve our understanding of the trial, regardless of outcome. The radiomics pilot seeks to provide a toolkit that is capable of analyzing the different modalities of information found in clinical trials (genome, gene expression, biomarker, clinical information, and imaging information) to derive insights into why a patient may be responding, or why a clinical trial was unsuccessful. The current efforts have focused on clinical trials in oncology, while collaborating with the RED-ONC function. Overall, the project is in its pilot state, and demonstrating a proof of concept, while documenting many challenges and learnings with the development of such a toolkit. Potential directions that could expand this toolbox include deriving the factors that best predict why a patient would stay in a clinical trial, and providing assistance with patient selection of clinical trials. Other potential directions involve suggesting why a particular trial may have been unsuccessful and providing that information back to the drug development team.

With the new head of R&D Community Engagement, RDCE, a new set-up has also been introduced, which newly regulates the tasks and responsibilities of the business partners assigned to the functions, SPOCs, which stands for Single Point of Contact. What is now in scope and what is not? The poster provides information on this.

The R&D Digital Fluency Program (DFP) is supporting you with learning offerings to build up competencies and further skillsets around digital technologies to enable a competitive and digitally literate organization. At the Digital Fluency Program, we set ourselves apart by offering learning opportunities created by your peers who understand the unique challenges you face in your job. Our tailored approach focuses on real-life use cases, taking our training far from generic and providing you relevant and impactful skill development. In 2020 we, a small team of four people, started our journey with the DFP as part of the R&D Digital Roadmap. Since technologies are ever evolving and impacting our work environment it is more important than ever to foster a culture of continuous learning and enable future opportunities. Thus the DFP learning portfolio includes something for everyone, regardless of your level of knowledge: It offers general awareness programs to enhance basic digital literacy, self-learning pathways on data analysis & visualization and the ability to access online courses like Coursera via the Digital Curriculum. The team ensured the learning objective was met by piloting newly developed learning programs, making use of cross-functional development, and incorporated R&D specific components prior to a broader roll-out in the organization.